ARCHIVES

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

This article is from The Cancer Letter archive.

Vol. 11 No. 10 | March 8, 1985

Download PDF Visit The Full Archive

Related Articles

Arzerra Promising For Heavily Pre-Treated CLL Patients

December 26, 2008

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.

November 28, 2003

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

TA To Release Report On Burton Therapy Requested By Congress

February 9, 1990

NCI CTEP Approved Trials For the Month of October

October 25, 2013